Evidence map›Paper›PMID 37755013›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

Anti-SARS-CoV-2 Agents in

Shoji Maehara, Shogo Nakajima, Koichi Watashi, Andria Agusta, Misato Kikuchi, Toshiyuki Hata, Kento Takayama

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. The Extract of the Endophytic FungusInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Shoji MaeharaFaculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.
Shogo NakajimaDepartment of Virology II, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.
Koichi WatashiDepartment of Virology II, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.
Andria AgustaResearch Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Jalan Raya Bogor Km 46, Cibinong, Bogor 16911, Indonesia.
Misato KikuchiFaculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.
Toshiyuki HataFaculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.
Kento TakayamaFaculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.
Fukuyama University · JPNational Institute of Infectious Diseases · JPNational Research and Innovation Agency · ID

Funding

Japan Science and Technology Agency JPMJSC15H1Japan Society for the Promotion of Science 23K06189
6 · The paper itself

Abstract

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic agents for the disease are being developed. Endophytes are diverse and produce various secondary metabolites and bioactive substances. We isolated 13 endophytes from the leaves and stems of

Indexed as

antivirusArtemisiaendophytic abundanceendophytic fungimetabarcodingSARS-CoV-2

Identifiers

PMID37755013
PMCPMC10532694
OpenAlexW4386456851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.